Page last updated: 2024-09-03

neo-gambogic acid and rhodamine 123

neo-gambogic acid has been researched along with rhodamine 123 in 1 studies

Compound Research Comparison

Studies (neo-gambogic acid)	Trials (neo-gambogic acid)	Recent Studies (post-2010) (neo-gambogic acid)	Studies (rhodamine 123)	Trials (rhodamine 123)	Recent Studies (post-2010) (rhodamine 123)
63	0	59	1,760	10	424

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, W; Guo, J; Xu, Q	1

Other Studies

1 other study(ies) available for neo-gambogic acid and rhodamine 123

Article	Year
Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism. Biochemical and biophysical research communications, 2019, 01-15, Volume: 508, Issue:3 Topics: Adenosine Triphosphatases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; NF-kappa B; Rhodamine 123; Xanthenes	2019

Article

Year

Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism.

Biochemical and biophysical research communications, 2019, 01-15, Volume: 508, Issue:3

Topics: Adenosine Triphosphatases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; NF-kappa B; Rhodamine 123; Xanthenes

2019